Upcoming Events


Jointly organised by the HKSAR Government, Hong Kong Trade Development Council and Hong Kong Design Centre, BIP Asia Forum brings IP professionals and business leaders from all over the world to discuss the latest developments in the IP world, and to explore business collaboration opportunities.

The 10th edition of BIP Asia Forum will be held on 3-4 December 2020 to focus on how open innovation drive businesses to collaborate with their partners and accelerate technological development through IP under a changing era. A dedicated session “Global Tech Summit” will focus on the world’s disruptive technologies and innovation trends.


Organisers:  Hong Kong Trade Development Council (HKTDC), HKSAR Government, Hong Kong Design Centre
Dates: 3-4 December 2020 (Thursday - Friday)
Venue: Online Forum
Supporting Organisations: Hong Kong Biotechnology Organization
Online Registration: http://www.hktdc.com/ncs/bip2020/en/s/fp-Onlineregistration.html

* Register with Hong Kong Biotechnology Organization’s promotion code SO20081SD to enjoy the special rate at HK$200 (Original rate: HK$550).

Contact us: Telephone: +852 1830 668| Email: bipasia@hktdc.org |  Website: http://bipasiaforum.com/en


Fear of “Poison”: Introduction to Threat of “Virus” to Humans

Date & Time: To be confirmed
Speaker: Dr. LI Xiaoyi Benjamin (Vice Chairman of Hong Kong Biotechnology Organization, Adjunct Professor at Hong Kong University of Science and Technology)
Organiser: Jointly organised by the Hong Kong Public Libraries and the Hong Kong Biotechnology Organization
Remarks: Conducted in Cantonese.
Telephone Number: 2921 0335
Wedsite: https://www.hkpl.gov.hk/en/extension-activities/event-detail/179920/fear-of-poison-introduction-to-threat-of-virus-to-humans


In view of the epidemic situation, the talk will be conducted via video recording without live audience. The talk video will be available on the Multimedia Information System of Hong Kong Public Libraries or other platforms. Please pay attention for further details to be announced later on the website of Hong Kong Public Libraries.

The speaker will provide the audience an in-depth and easy-to-comprehend introduction to threat of viruses to human lives from the perspective of biotechnology.

Our knowledge of viruses is still badly inadequate while modern medical biotechnology and scientific knowledge are advancing by leaps and bounds. Humans are making progress, whereas viruses are constantly mutating and adapting. Nowadays, with frequent global interchanges and dense urban populations, the threat of viruses to humans will only become more frequent and more difficult to prevent.

It is expected that the talk would enhance audience’s understanding in how the modern biotechnology and medical advancements contribute to therapy for diseases caused by viruses and other new medical treatments of viral infections. 


 【大会简介】为了发挥“2020中国精准医学大会、2020中国生命科学大会”的学术价值及影响力,响应党 中央“一带一路”倡议和“实施健康中国战略”的号召,由国家卫生健康委支持指导,中国医院协 会主办,广东标杆会展有限公司承办的2020中国精准医学大会、2020中国生命科学大会及展览 会,将于2020年12月26-28日在广州保利世贸博览馆召开。

为进一步促进我国精准医学及生命科学实现跨越式创新发展,也为展示我国科学家在精准医学 及生命科学领域的实力和创新性成果、促进多学科交叉融合、推动上下游产业间的交流合作。

本届大会将聚焦科学前沿和健康促进的热点问题,在保持生命科学前沿交流的基础上,进一步 侧重我国及发展中国家更为关注的健康促进、慢病防控和老龄化应对等热点问题。

聚焦生命科学领域前沿进展、生物技术领域风向标以及健康领域民众普遍关注的热点,开展高 水平的学术交流和最新成果展示,推动生命科学研究和技术创新取得更多突破,大会一方面将提高 会议学术交流的效率,另一方面凸显生命科学进展在人类健康共同体构建中的作用,将是世界生命 科学和中国生命科学界的一次盛会。

大会同期附设世界生命科学展,本次展览将为国内外生物技术企业及研发机构提供与世界优秀 的科研团队进行近距离交流的难得机会和展示实力、推广产品、拓展市场的良好契机。

【往屆回顧】首屆粵港澳大灣區生物科技創新企業50 強評選2018 年6 月啟動,已連續舉辦兩屆,獲得了政府相關部門、創投機構、生物科技企業以及媒體的廣泛關注與大力支持。50 強評委顧問團由三十多位來自政府機構、第三方研究、專業投資和醫療機構的專業人士組成,他們從領先技術應用與突破、市場應用、估值及資本市場認可度三個維度出发,全面評估參選企業的技術創新度和未來发展前景。
第二屆50 強榜單中,醫療器械領域占36%,生物醫藥占34%,精準醫療占24%,醫療服務占6%;其中,廣州、深圳和香港占比合計約90%,其他珠三角城市合計約10%,一定程度上體現了大灣區生物醫藥產業发展格局。第二屆50 強評選還发布了《粵港澳大灣區生物科技企業50 強創新報告》,圍繞入榜企業舉辦了50 強專項路演、企業回訪等多項精準對接,助力生物科技企業跨界融合,促進粵港澳大灣區生物醫藥產業向集聚化、產業化和國際化方向发展。
【2020 再出发】粵港澳大灣區是我國生物醫藥產業的三大集聚區之一,是國家发展戰略的城市群,《粵港澳大灣區发展規劃綱要》提出,推動新一代信息技術、生物技術、高端裝備制造、新材料等发展壯大為新支柱產業。唯有科技與創新能超越平凡,科技創新成為粵港澳大灣區建設的重中之重!舉辦“粵港澳大灣區生物技術創新”評選活動,正是順應國家发展戰略下的行業融合发展。2020,第三屆粵港澳大灣區生物科技創新企業50 強評選強勢來襲,发掘大灣區生物科技行業未來獨角獸,推動生物科技行業縱深发展!


BIOHK2021 Banner 3 s

Hong Kong, being the gateway to China, provides a rich source of opportunities for overseas investors looking to capitalize on the growth of the Greater Bay Area (GBA). Meanwhile, for companies from China, Hong Kong is a bridge to connect with the West. Moreover, the new listing rules adopted by the Hong Kong Stock Exchange (HKEX) which allow pre-revenue biotech companies to be listed on the HKEX is a bold imperative step for the growth of the biotech sector in Hong Kong. Thus, we could not think of a better way to kick-start the Asian biotech revolution than by organizing BIOHK2021 convention in Hong Kong, the potential biotech epicentre of Asia. This is a golden opportunity to personally view the major GBA cities involved in the future of biotechnology by becoming a part of this historical event.

Free Joomla! template by Age Themes